Solventum Corporation <SOLV.N>: Stifel raises target price to $100 from $90
SOLV•Related News
Globalstar Q2 FY26 swings to net loss of $26.5 million; revenue falls 5% to $64.8 million
GSAT•
Twin Vee Q2 FY26 net loss widens 75% to $2.9 million; net sales drop 34% to $3.13 million
VEEE•
Nano-X Imaging prices USD 8 million registered direct offering at USD 1 per share with warrants
NNOX•
Lemaitre Vascular, Inc. <LMAT.O>: Barrington Research Raises to Outperform From Market Perform
LMAT•
Pacira publishes positive two-year Phase 1 data for PCRX-201 gene therapy in knee osteoarthritis
PCRX•